trending Market Intelligence /marketintelligence/en/news-insights/trending/rq-_5m-xrkfob2xmrmubea2 content esgSubNav
In This List

Report: Nordic Capital withdraws bid for Sanofi's European generic drugs unit

Blog

Banking Essentials Newsletter: October Edition

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Report: Nordic Capital withdraws bid for Sanofi's European generic drugs unit

Nordic Capital Ltd. withdrew its bid to acquire Sanofi's European generic drugs unit due to high price expectations, the Financial Times reported, citing people familiar with the matter.

According to the sources, the European private equity firm was considering a team-up with U.S.-based Blackstone Group LP to acquire the unit, which Sanofi is looking to sell for up to €2 billion.

With Nordic Capital out, Advent International Corp., BC Partners Ltd. and Carlyle Group LP, as well as at least one pharma company, remain as bidders for the business, the Financial Times said.

The next deadline for bids is reportedly in April.